Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + high-dose amoxicillin dual therapy regimens for first-line Helicobacter pylori eradication
ChiCTR2400079754Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan and amoxicillin in Helicobacter pylori infection (4 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Helicobacter pylori eradication rate. Started Oct 2023; status: recruiting.
02
Drugs
vonoprazanamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2400079754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079754.